{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-22-009675","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2022-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.625467+00:00","generated_at":"2026-06-24T03:23:08.200066+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Alzamend Neuro CFO Lien Escalona resigns; COO David Katzoff appointed as new CFO","bullets":["Lien Escalona resigned as CFO effective August 1, 2022.","David J. Katzoff, previously COO, appointed CFO on August 5, 2022.","Katzoff joined Alzamend in Nov 2019 as SVP Operations, then COO from Dec 2020.","Katzoff also serves as SVP Finance of BitNile Holdings and CFO of Imperalis Holding Corp.","No employment agreement or compensation change for Katzoff at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-22-009675","json":"https://secwatch.observer/filing/0001214659-22-009675.json","markdown":"https://secwatch.observer/filing/0001214659-22-009675.md","text":"https://secwatch.observer/filing/0001214659-22-009675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/e842248k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:23:08.200066+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"119592ac47","claim":"David J. Katzoff was appointed as Chief Financial Officer at Alzamend Neuro, Inc..","evidence_excerpt":"On August 5, 2022, the Company appointed David J. Katzoff, who has been serving as the Company’s Chief Operating Officer, as its new Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e688ad0f27","claim":"Lien Escalona resigned as Chief Financial Officer at Alzamend Neuro, Inc..","evidence_excerpt":"On August 1, 2022, Lien Escalona resigned as the Chief Financial Officer of Alzamend Neuro, Inc. (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}